Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IM and ID fIPV in Routine Infant Immunization
NCT04063150Phase 4Terminated
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Oct 2019
- Primary completion
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trivalent inactivated polio vaccine in poliomyelitis (7 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Vaccine response. Started Oct 2019; status: terminated.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04063150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04063150.